WebJan 22, 2024 · Dr Fiona Marshall joins MSD (Merck & Co. in North America) from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015. WebAug 11, 2010 · Fiona Marshall, PhD, an archaeologist in the Department of Anthropology in Arts & Sciences at Washington University in St. Louis, was installed Feb. 10 as the inaugural James W. and Jean L. Davis Professor. The professorship is named in tribute to the lifelong contributions of the Davises to the university.
Fiona Marshall - Head of Public Sales - Promega …
WebJan 2015. The prize has been awarded to Miles Congreve, Fiona Marshall and Malcolm Weir for the seminal contributions to GPCR drug discovery … WebFiona Marshall, PhD Vice President, Head of Neuroscience Discovery Head of Discovery Research, MRL UK Fiona Marshall serves as Vice President, Head of Neuroscience Discovery and Head of Discovery Research in London, focused on research into diseases of aging. Previously, Fiona was Chief Scientific Officer at Sosei Heptares. She was a … clprng
Fiona Marshall Profile University of Sussex
WebSep 1, 2024 · Fiona H. Marshall, Ph.D., currently Senior Vice President and Global Head of Discovery Sciences, Preclinical Development and Translational Medicine at MSD (Merck & Co., Inc in USA), has been ... WebJul 17, 2024 · July 17, 2024 - 6 minutes. Heptares is expanding into a range of indications with its GPCR platform. I caught up with CSO & co-founder Fiona Marshall to hear more about the strategy. Fiona Marshall has always worked on G-protein coupled receptors, or GPCRs for short. These entities are key to many eukaryotic signaling pathways, and … WebFiona Marshall is VP Head of the UK Discovery Centre, MSD Research Laboratories. She has more than 25 years' experience in drug discovery and development across Pharma and Biotech companies. Previously Fiona was VP and CSO of the Japanese Biotech company Sosei Group which acquired Heptares Therapeutics in 2015. cabinet office annual revenue